KBC Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

KBC Group’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,317	Closed	-$66K	–	1536
2023 Q1	$66K	Sell	3,317 -755	-19%	-$13K	﹤0.01%	1327
2022 Q4	$55K	Hold	4,072	–	–	﹤0.01%	1366
2022 Q3	$56K	Hold	4,072	–	–	﹤0.01%	1367
2022 Q2	$58K	Sell	4,072 -18,318	-82%	-$318K	﹤0.01%	1395
2022 Q1	$506K	Buy	22,390 +12,640	+130%	+$245K	﹤0.01%	810
2021 Q4	$183K	Hold	9,750	–	–	﹤0.01%	1085
2021 Q3	$320K	Buy	+9,750	New	+$364K	﹤0.01%	981
2021 Q1	–	Sell	-524	Closed	-$23K	–	1324
2020 Q4	$23K	Buy	+524	New	+$19.7K	﹤0.01%	1248

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

KBC Group's CSII Position: Q2 2023 in Review

KBC Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 3,317 shares — an estimated $66K sold.

KBC Group first reported a position in CSII in Q4 2020 and held it in 8 quarters. The position peaked at $506K in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

KBC Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
KBC Group sold 3,317 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $66K.
KBC Group first reported a position in Cardiovascular Systems, Inc. in Q4 2020 and held it in 8 quarters.
KBC Group's Cardiovascular Systems, Inc. position peaked at $506K in Q1 2022.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on KBC Group's 13F filing for Q2 2023, filed 28 Jul 2023.